These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 20832553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.
    Ponton C, Vizcaíno L, Tomé S, Otero E, Molina E, Castroagudín JF, López-Lago A, Varo Pérez E.
    Transplant Proc; 2010 Mar; 42(2):656-9. PubMed ID: 20304216
    [Abstract] [Full Text] [Related]

  • 4. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI, Quiroga J, Sangro B, Girala M, Gómez-Manero N, Pardo F, Alvárez-Cienfuegos J, Prieto J.
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction.
    Koch RO, Graziadei IW, Schulz F, Nachbaur K, Königsrainer A, Margreiter R, Vogel W.
    Transpl Int; 2004 Oct; 17(9):518-24. PubMed ID: 15365603
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Klupp J, Glanemann M, Junge G, Pfitzmann R, Bahra M, Radtke C, Neumann U, Neuhaus R, Neuhaus P.
    Clin Transplant; 2006 Oct; 20(3):272-83. PubMed ID: 16824141
    [Abstract] [Full Text] [Related]

  • 7. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA, Stone JJ, Wolfe LG, Rodgers CM, Anderson ML, Sterling RK, Shiffman ML, Luketic VA, Contos MJ, Mills AS, Ferreira-Gonzalez A, Posner MP.
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [Abstract] [Full Text] [Related]

  • 8. Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.
    Herlenius G, Felldin M, Nordén G, Olausson M, Bäckman L, Gustafsson B, Friman S.
    Transplant Proc; 2010 Dec; 42(10):4441-8. PubMed ID: 21168715
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction.
    Cantarovich M, Tzimas GN, Barkun J, Deschênes M, Alpert E, Tchervenkov J.
    Transplantation; 2003 Jul 15; 76(1):98-102. PubMed ID: 12865793
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 11. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J.
    Transplantation; 2004 Jan 27; 77(2):244-51. PubMed ID: 14742989
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G, Burke GW, Gaynor JJ, Roth D, Sageshima J, Kupin W, Tueros L, Hanson L, Rosen A, Ruiz P, Miller J.
    Transplantation; 2008 Jul 15; 86(1):67-74. PubMed ID: 18622280
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.
    Moreno JM, Rubio E, Gómez A, Lopez-Monclus J, Herreros A, Revilla J, Navarrete E, Sánchez Turrión V, Jimenez M, Cuervas-Mons V.
    Transplant Proc; 2003 Aug 15; 35(5):1874-6. PubMed ID: 12962831
    [Abstract] [Full Text] [Related]

  • 15. Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant.
    Biselli M, Vitale G, Gramenzi A, Riili A, Berardi S, Cammà C, Scuteri A, Morelli MC, Grazi GL, Pinna AD, Andreone P, Bernardi M.
    Clin Transplant; 2009 Aug 15; 23(2):191-8. PubMed ID: 19210525
    [Abstract] [Full Text] [Related]

  • 16. Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil.
    Doria C, Ramirez CB, Frank AM, Vaccino S, Fraser N, Marino IR.
    Clin Transplant; 2009 Aug 15; 23(6):882-6. PubMed ID: 19573090
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil combination therapy improves survival after liver transplantation. A single-center retrospective analysis.
    Zahn A, Müeller F, Hinz U, Schemmer P, Stremmel W, Ganten T.
    Ann Transplant; 2013 Oct 03; 18():525-32. PubMed ID: 24088725
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results.
    Reich DJ, Clavien PA, Hodge EE, MMF Renal Dysfunction after Liver Transplantation Working Group.
    Transplantation; 2005 Jul 15; 80(1):18-25. PubMed ID: 16003228
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 Jul 15; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients.
    Pfitzmann R, Klupp J, Langrehr JM, Uhl M, Neuhaus R, Settmacher U, Steinmüller T, Neuhaus P.
    Transplantation; 2003 Jul 15; 76(1):130-6. PubMed ID: 12865798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.